{"name":"Oyster Point Pharma, Inc.","slug":"oyster-point-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Tyrvaya Nasal Pump","genericName":"Tyrvaya Nasal Pump","slug":"tyrvaya-nasal-pump","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Tyrvaya Nasal Pump","genericName":"Tyrvaya Nasal Pump","slug":"tyrvaya-nasal-pump","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQMVk1dElwZHpKM2p1UkJKZ0tBbHZMMDV3a1BIWURPTkdqOExqejNzOGtILVZWYXE3NzU0dzJkUmV6MUE0aXkyZUhQckJnSjJQYW1SdGxGdGhsRURodE9STnNkOVd3bXZmNjh5R2N4YjBwMWRwYlNTYXVsa2JsZGE5MA?oc=5","date":"2025-12-27","type":"pipeline","source":"Stanford Medicine","summary":"OysterPoint - Stanford Medicine","headline":"OysterPoint","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQVGRyTzZGdU5wX1pGV2RPanZCa2s2ZjhhSTU1c2hMYkszVGNxdFItVVZRY19HUy02ZlpaVlRmWC15eWc4ek5XQnotYmNZN2ZqcV9kaUVIbWZvSXd0UDFERGsxM3l1LUxseXJwNHQ3T2EzUUlILVRsbDJBd0xoTnhac2lXWVZYaFUwSDJ3bXNaSkNCMmtrWHFEbFFQdmxoRWZQcTJTZDluZ3dJSW5FNFJz?oc=5","date":"2025-10-30","type":"pipeline","source":"The Business Journals","summary":"Acadia Pharma plots space to grow at Kilroy's big South San Francisco campus - The Business Journals","headline":"Acadia Pharma plots space to grow at Kilroy's big South San Francisco campus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxOc3dLSjcyZTdBWGlMV3ZGNVUtUW5mdzRvMDZDbVBHWUZZSUpoQVpVaF9QclZQazV0dHd2Z21VSnRXTFQ0U3VJcHBpRmg3eVFzSnFvLXVBN05YTERJY1V1c0dUZmVzcnk4NFk5akZzcW5CZnlCcFcwa1dMTHVNaDRzWEpZbzE1YTZET0xwMEVWT3YyMzY1cmJFdXRNSkdpSnFRYk1jZ05KLV8xSDJFN1YyVDZOLVZqdGpEamw3T1gzblhsUEpiWGtjY3JVLWtwc0RiYWk2Ui1nV2hoMUVuLTJHTm1TdXBqWnB2UXI3bzJ0Q0pQM1pEZzhNMC1qUkswWndpVlE?oc=5","date":"2023-01-03","type":"pipeline","source":"PR Newswire","summary":"Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division - PR Newswire","headline":"Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNb1RpQXg0MGpaRTFqVW1VTlJpUkFmdzZTbUVlbzZsNUFSS01Ecm5MaEpTT2RoXzJnOWRDQWJaNnVrWlNiMUo4bWNjWlBvSnhhTXZoN2UyT0RDd0NkS19qY3pxQVNoQ29oMERKcWgzZzFwYVdWdXNvcS01cWQxYkQ2Y3FETHNacjJjX0xERzBOWkZhZGNNTXVpbXZTVzNWdjhNeWhMeVdMcXdjelV3?oc=5","date":"2023-01-03","type":"deal","source":"Eyes On Eyecare","summary":"Viatris officially acquires Oyster Point Pharma, Famy Life Sciences - Eyes On Eyecare","headline":"Viatris officially acquires Oyster Point Pharma, Famy Life Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1zc2poUFFaQzVnX2ZsTFJaWjBCbWNtVUpnb1FiNXM5T3ZlaS1mZkstaU85MDJkQ2pDQVd5ay1pdkV5VFRpemQ4TGdTMi1PUVY0eDQwLWk5ZzdaWGtQSEtycFkxdE5lQW0xaVk3VUFWaTVwZUlKendfcWkzNGJvUQ?oc=5","date":"2022-11-08","type":"deal","source":"Pharmaceutical Technology","summary":"Viatris agrees to acquire Oyster Point and Famy Life Sciences - Pharmaceutical Technology","headline":"Viatris agrees to acquire Oyster Point and Famy Life Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQVTBjSW5TYVFGMnRodFQxZzNvQ2xmNXgxdThxenVvSFdGaWVJeXVZQUJaUllXeUdPUWY2ZUxtNmNmVVgwa0FHcW5PT1ZPUGhtM2hWelhqVnd3a1FxUnZhd29xOEthZ3d4cGxQTVdDRGZsMWF0MGFDQzFXdmlud21Ec3pWUGdiZGN2MlprX3dVOFRVLTBVX0NuNHhRdlUtVmctMUk0U3lielhMYTBiY0tMZ1dnRQ?oc=5","date":"2022-11-07","type":"pipeline","source":"Ophthalmology Times","summary":"Viatris making ophthalmology push with acquisition of Oyster Point Pharma - Ophthalmology Times","headline":"Viatris making ophthalmology push with acquisition of Oyster Point Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxOX3B6RERuTElhLTR1TlNfb1UwYWd6N3VpQVR6WnhvUlZoZzJkcHZFVDJWODlSVUJMSDZHd29OVVhNdHJZUkM0NS10UnBQOEJoYnpKM3NQOVNId1dZcHpSNmNHWTV2X1NHODNPSGhneS1SSktvWlJGWDI2MmNJaG96RXZ2YWZmTV9ZWHhTaGJEb1RLNm8tYU13UzBqenRLYkd3ZkUyeWtEN1Fzd3AxN0Y1ZnhWUmxnS3VIc2N1ZkViX1MtSDVzSDIwU2drTXpPNzhCbGU5dlFmbGxLNHVNNXV1eWVIQTJHRVBFWWI0bnkzaU9XVWhRdkVIMkw0M1QxcWlhWXEwS2RB?oc=5","date":"2022-11-07","type":"deal","source":"GlobeNewswire","summary":"Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris - GlobeNewswire","headline":"Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNUGZLNkhVMG5vRUVhblRmY2dRcC1pc3NtREtubXF5U2d4TUdBUl9CQkE2X2RmT0xKVTRJN19sckRGQUZsQXJnd1F5M0g2eENTVnQzX252SHBpazEyOGdJZ0VqS2t5TGl2ZTB4MTY1bGpfeEdReHBFTDZVVXVsS2FSaERuZE1qTlRRQnA1cnR6bGN3NnRw?oc=5","date":"2022-11-07","type":"deal","source":"BioPharma Dive","summary":"Viatris to buy two eye drug developers in deals worth up to $750M - BioPharma Dive","headline":"Viatris to buy two eye drug developers in deals worth up to $750M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQSFJqYnRkNVFsSzN5TGRCaFY0amRGbHdpbG12VVNiNDlteThzYjJRUzVEdE5BUHRLVmRKZHhDdFBrcllwVHJMeHZqR3NBU0Z4dE53MzBQLXpxSUd2aThaaXUxSG5uUjNEeDFSOWFXakVCWk1nMWtZUzJMRkNVa01OU0U1YmNrZE1JNWF3X0ktOW94Z2ZHTkJ5RGVremNKcFdMWjE3anFNVnd0VWh3SjVKeGxiTzBVRmNrVWhuUE5KdUFWdnktZTE4?oc=5","date":"2022-11-07","type":"deal","source":"Fierce Pharma","summary":"Viatris jumps into ophthalmology arena with pair of buyouts worth up to $750M - Fierce Pharma","headline":"Viatris jumps into ophthalmology arena with pair of buyouts worth up to $750M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQaGstUll5NWRMZGtkbTRkNWRXZnlZU0s1ZnNCaFFwcmVPajVTOGZRN1Y2b1JES0oyVndVZzVKZjAwT3JtenBMM1R4dnVZczcwYjNMRTktSDZ3a3JyM0kySmVZYTlGc3kxZjkwdE56S2g3WXlwMWlYd0w3UnREaC1WMndfSQ?oc=5","date":"2022-11-07","type":"deal","source":"BioSpace","summary":"Viatris Acquires Oyster Point, Gains Access to Ophthalmic Pipeline - BioSpace","headline":"Viatris Acquires Oyster Point, Gains Access to Ophthalmic Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxObjY4UWFJcVVfWnJ3SzZSV3ByWUdKRGFlQXN3Q0tuMV8xSWowemhEMnN5ajhzdzhhZmVzdGU2Tk80cFAzTW9BTWhWYUhnODI3VlFVTjJJLXh3bHRYS0o4TjBUc2ZmdkppMldWNm44dWQxemlnUzVVNXh5QU80WWZ0NnE2TlY4TXhSaTV4YWdTQjF3QTFTdTJQbEdSNExvOG8?oc=5","date":"2022-11-07","type":"deal","source":"citybiz","summary":"Viatris Acquires Oyster Point Pharma and Famy Life Sciences - citybiz","headline":"Viatris Acquires Oyster Point Pharma and Famy Life Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNb2FMT0ZqVk91eTBBa1VOV2JsRVhhQXpma1A5MXh0X3RhV3k1YmlXZ1FfVmw4am9aMF83b0xwUEhtM1VpQnVBQmczWFgxWE1vdklIU2c2b3ZVUlNQVHZneFF5T1MxS3ZaRHpxMDdzVW5QQjVCOTN6akh5N1BVNWVjajdWZGJvU3hLeXNNTHdDR1lYNklpd2lLUlVtdUl4V0hjcVg1QUZBbEZwTU8wdVUwZGRtOU5aYk8wM2RJZ0YxN1YtakVh?oc=5","date":"2021-10-18","type":"regulatory","source":"Reuters","summary":"Oyster Point's drug becomes first FDA-approved nasal spray to treat dry eyes - Reuters","headline":"Oyster Point's drug becomes first FDA-approved nasal spray to treat dry eyes","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}